Innovation Pharmaceuticals Announces Publication of Independent Research on Kevetrin, the Company's p53 Drug Candidate, in Oncology Reports
Stock Information for Innovation Pharmaceuticals Inc
Loading
Please wait while we load your information from QuoteMedia.